Annual Current Liabilities
$225.41 M
+$130.54 M+137.62%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual total current liabilities is currently $225.41 million, with the most recent change of +$130.54 million (+137.62%) on 31 December 2023. During the last 3 years, it has risen by +$113.21 million (+100.90%). AMPH annual current liabilities is now at all-time high.AMPH Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$159.01 M
+$22.04 M+16.09%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly total current liabilities is currently $159.01 million, with the most recent change of +$22.04 million (+16.09%) on 30 September 2024. Over the past year, it has dropped by -$98.95 million (-38.36%). AMPH quarterly current liabilities is now -38.36% below its all-time high of $257.96 million, reached on 30 September 2023.AMPH Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +137.6% | -38.4% |
| 3 y3 years | +100.9% | +62.3% |
| 5 y5 years | +111.0% | +83.6% |
AMPH Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +137.6% | -38.4% | +67.6% |
| 5 y | 5 years | at high | +150.4% | -38.4% | +90.7% |
| alltime | all time | at high | +276.0% | -38.4% | +182.5% |
Amphastar Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $159.01 M(+16.1%) |
| June 2024 | - | $136.97 M(-46.3%) |
| Mar 2024 | - | $255.17 M(+13.2%) |
| Dec 2023 | $225.41 M(+137.6%) | $225.41 M(-12.6%) |
| Sept 2023 | - | $257.96 M(+2.7%) |
| June 2023 | - | $251.28 M(+137.9%) |
| Mar 2023 | - | $105.64 M(+11.4%) |
| Dec 2022 | $94.86 M(-8.6%) | $94.86 M(-7.2%) |
| Sept 2022 | - | $102.19 M(-1.4%) |
| June 2022 | - | $103.63 M(-9.4%) |
| Mar 2022 | - | $114.36 M(+10.2%) |
| Dec 2021 | $103.81 M(-7.5%) | $103.81 M(+5.9%) |
| Sept 2021 | - | $97.99 M(-21.3%) |
| June 2021 | - | $124.55 M(-2.0%) |
| Mar 2021 | - | $127.10 M(+13.3%) |
| Dec 2020 | $112.20 M(+24.7%) | $112.20 M(+16.0%) |
| Sept 2020 | - | $96.72 M(+3.7%) |
| June 2020 | - | $93.29 M(+11.9%) |
| Mar 2020 | - | $83.37 M(-7.4%) |
| Dec 2019 | $90.01 M | $90.01 M(+3.9%) |
| Sept 2019 | - | $86.60 M(-14.3%) |
| June 2019 | - | $101.00 M(-9.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $111.96 M(+4.8%) |
| Dec 2018 | $106.83 M(+59.0%) | $106.83 M(+10.6%) |
| Sept 2018 | - | $96.62 M(+10.3%) |
| June 2018 | - | $87.59 M(+20.7%) |
| Mar 2018 | - | $72.54 M(+8.0%) |
| Dec 2017 | $67.19 M(+10.8%) | $67.19 M(+17.1%) |
| Sept 2017 | - | $57.40 M(-9.9%) |
| June 2017 | - | $63.70 M(-12.6%) |
| Mar 2017 | - | $72.86 M(+20.2%) |
| Dec 2016 | $60.62 M(+1.1%) | $60.62 M(-0.4%) |
| Sept 2016 | - | $60.84 M(-7.4%) |
| June 2016 | - | $65.67 M(+1.1%) |
| Mar 2016 | - | $64.92 M(+8.3%) |
| Dec 2015 | $59.95 M(-4.2%) | $59.95 M(-15.1%) |
| Sept 2015 | - | $70.65 M(+1.8%) |
| June 2015 | - | $69.40 M(-3.7%) |
| Mar 2015 | - | $72.09 M(+15.2%) |
| Dec 2014 | $62.59 M(-4.3%) | $62.59 M(-0.8%) |
| Sept 2014 | - | $63.08 M(+12.1%) |
| June 2014 | - | $56.28 M(-22.7%) |
| Mar 2014 | - | $72.81 M(+11.3%) |
| Dec 2013 | $65.40 M(+8.9%) | $65.40 M |
| Dec 2012 | $60.08 M | - |
FAQ
- What is Amphastar Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual current liabilities year-on-year change?
- What is Amphastar Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly current liabilities year-on-year change?
What is Amphastar Pharmaceuticals annual total current liabilities?
The current annual current liabilities of AMPH is $225.41 M
What is the all time high annual current liabilities for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual total current liabilities is $225.41 M
What is Amphastar Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, AMPH annual total current liabilities has changed by +$130.54 M (+137.62%)
What is Amphastar Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of AMPH is $159.01 M
What is the all time high quarterly current liabilities for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly total current liabilities is $257.96 M
What is Amphastar Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, AMPH quarterly total current liabilities has changed by -$98.95 M (-38.36%)